87 related articles for article (PubMed ID: 31970828)
21. Deleterious effects of increased body weight associated with intensive insulin therapy for type 1 diabetes: increased blood pressure and worsened lipid profile partially negate improvements in life expectancy.
Palmer AJ; Roze S; Valentine WJ; Minshall ME; Lammert M; Nicklasson L; Spinas GA
Curr Med Res Opin; 2004 Aug; 20 Suppl 1():S67-73. PubMed ID: 15324518
[TBL] [Abstract][Full Text] [Related]
22. The relative burden of diabetes complications on healthcare costs: The population-based CINECA-SID ARNO Diabetes Observatory.
Pagano E; De Rosa M; Rossi E; Cinconze E; Marchesini G; Miccoli R; Vaccaro O; Bonora E; Bruno G
Nutr Metab Cardiovasc Dis; 2016 Oct; 26(10):944-50. PubMed ID: 27289165
[TBL] [Abstract][Full Text] [Related]
23. Gender differences in diabetes self-care in adults with type 1 diabetes: Findings from the T1D Exchange clinic registry.
Shah VN; Wu M; Polsky S; Snell-Bergeon JK; Sherr JL; Cengiz E; DiMeglio LA; Pop-Busui R; Mizokami-Stout K; Foster NC; Beck RW;
J Diabetes Complications; 2018 Oct; 32(10):961-965. PubMed ID: 30121205
[TBL] [Abstract][Full Text] [Related]
24. Health-economic comparison of continuous subcutaneous insulin infusion with multiple daily injection for the treatment of Type 1 diabetes in the UK.
Roze S; Valentine WJ; Zakrzewska KE; Palmer AJ
Diabet Med; 2005 Sep; 22(9):1239-45. PubMed ID: 16108855
[TBL] [Abstract][Full Text] [Related]
25. A Patient-Level Model to Estimate Lifetime Health Outcomes of Patients With Type 1 Diabetes.
Tran-Duy A; Knight J; Palmer AJ; Petrie D; Lung TWC; Herman WH; Eliasson B; Svensson AM; Clarke PM
Diabetes Care; 2020 Aug; 43(8):1741-1749. PubMed ID: 32532756
[TBL] [Abstract][Full Text] [Related]
26. Management of type 1 diabetes in low- and middle-income countries: Comparative health system assessments in Kyrgyzstan, Mali, Peru and Tanzania.
Abdraimova A; Besançon S; Portocarrero J; Ramaiya K; Dunganova A; Ewen M; Hogerzeil H; Lazo-Porras M; Laing R; Lepeska M; Nchimbi H; Sidibé A; Swai A; Tenorio-Mucha J; Yudkin JS; Zafra-Tanaka JH; Zurdinova A; Beran D
Diabet Med; 2022 Aug; 39(8):e14891. PubMed ID: 35621029
[TBL] [Abstract][Full Text] [Related]
27. The 3C study: coverage cost and care of type 1 diabetes in China--study design and implementation.
McGuire H; Kissimova-Skarbek K; Whiting D; Ji L
Diabetes Res Clin Pract; 2011 Nov; 94(2):307-10. PubMed ID: 22056720
[TBL] [Abstract][Full Text] [Related]
28. Prospective study of incidence of juvenile diabetes mellitus over 10 years in Dar es Salaam, Tanzania.
Swai AB; Lutale JL; McLarty DG
BMJ; 1993 Jun; 306(6892):1570-2. PubMed ID: 8329915
[TBL] [Abstract][Full Text] [Related]
29. Rates of diabetic ketoacidosis: international comparison with 49,859 pediatric patients with type 1 diabetes from England, Wales, the U.S., Austria, and Germany.
Maahs DM; Hermann JM; Holman N; Foster NC; Kapellen TM; Allgrove J; Schatz DA; Hofer SE; Campbell F; Steigleder-Schweiger C; Beck RW; Warner JT; Holl RW;
Diabetes Care; 2015 Oct; 38(10):1876-82. PubMed ID: 26283737
[TBL] [Abstract][Full Text] [Related]
30. Effect of infant mortality on subsequent fertility in Pakistan and Sri Lanka.
Rao KV; Beaujot R
J Biosoc Sci; 1986 Jul; 18(3):297-303. PubMed ID: 3745231
[TBL] [Abstract][Full Text] [Related]
31. Self-monitoring of blood glucose (SMBG) for type 2 diabetes patients treated with oral anti-diabetes drugs and with a recent history of monitoring: cost-effectiveness in the US.
Tunis SL; Minshall ME
Curr Med Res Opin; 2010 Jan; 26(1):151-62. PubMed ID: 19919376
[TBL] [Abstract][Full Text] [Related]
32. Assessing the cost-effectiveness of type 1 diabetes interventions: the Sheffield type 1 diabetes policy model.
Thokala P; Kruger J; Brennan A; Basarir H; Duenas A; Pandor A; Gillett M; Elliott J; Heller S
Diabet Med; 2014 Apr; 31(4):477-86. PubMed ID: 24299192
[TBL] [Abstract][Full Text] [Related]
33. The variation of psychopharmacological prescription rates for people with autism spectrum disorder (ASD) in 30 countries.
Wong AY; Hsia Y; Chan EW; Murphy DG; Simonoff E; Buitelaar JK; Wong IC
Autism Res; 2014 Oct; 7(5):543-54. PubMed ID: 24895332
[TBL] [Abstract][Full Text] [Related]
34. Direct medical costs for complications among children and adults with diabetes in the US commercial payer setting.
Yeaw J; Halinan S; Hines D; Delozier A; Perez M; Boye M; Boye KS; Blanchette CM
Appl Health Econ Health Policy; 2014 Apr; 12(2):219-30. PubMed ID: 24573912
[TBL] [Abstract][Full Text] [Related]
35. Health-economic analysis of real-time continuous glucose monitoring in people with Type 1 diabetes.
Roze S; Saunders R; Brandt AS; de Portu S; Papo NL; Jendle J
Diabet Med; 2015 May; 32(5):618-26. PubMed ID: 25483869
[TBL] [Abstract][Full Text] [Related]
36. Glycemic control and clinic attendance of emerging adults with type 1 diabetes at a transition care clinic.
Levy-Shraga Y; Elisha N; Ben-Ami M; Boyko V; Lerner-Geva L; Ziv T; Konvalina N; Cohen O; Pinhas-Hamiel O
Acta Diabetol; 2016 Feb; 53(1):27-33. PubMed ID: 25794880
[TBL] [Abstract][Full Text] [Related]
37. Comparative Analysis of Prescription Drug Prices in South Asian Association for Regional Cooperation Countries.
Rohra DK; Abuomar OA; Cahusac PMB; Dangol A; Ranasinghe P
Value Health Reg Issues; 2020 May; 21():113-119. PubMed ID: 31706178
[TBL] [Abstract][Full Text] [Related]
38. Current status of diabetes management, glycemic control and complications in children and adolescents with diabetes in Egypt. Where do we stand now? And where do we go from here?
Samahy MH; Elbarbary NS; Elmorsi HM
Diabetes Res Clin Pract; 2015 Mar; 107(3):370-6. PubMed ID: 25649911
[TBL] [Abstract][Full Text] [Related]
39. Diabetes-Related Complications and Mortality in Patients With Young-Onset Latent Autoimmune Diabetes: A 14-Year Analysis of the Prospective Hong Kong Diabetes Register.
Luk AOY; Lau ESH; Lim C; Kong APS; Chow E; Ma RCW; Chan JCN
Diabetes Care; 2019 Jun; 42(6):1042-1050. PubMed ID: 30967437
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
